Gene · 6646
Papers1,513
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,513
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The ER membrane protein complex acts as a chaperone to promote the biogenesis of multi-bundle membrane proteins. | bioRxiv | 2026 | 41648177 | PubTator, text mining | PubMed |
| A genome-wide association meta-analysis of cholesterol synthesis intermediates identifies three associations for lanosterol. | EBioMedicine | 2026 | 41619350 | PubTator, text mining | PubMed |
| Lactate-lactylation in tumor angiogenesis and progression: mechanisms, biomarker potential, and therapeutic implications. | Biomark Res | 2026 | 41593811 | PubTator, text mining | PubMed |
| Rho/ROCK signaling and α-catenin mediate β-catenin-driven hyperplasia in the adrenal cortex via adherens junctions. | J Clin Invest | 2026 | 41591811 | PubTator, text mining | PubMed |
| SREBP-1 upregulates SOAT1 to promote tumor growth by preventing lipotoxicity. | Cell Rep | 2026 | 41581144 | PubTator, text mining | PubMed |
| Role of Oxysterol-Binding Protein Family in Cholesterol Metabolism and Cancer Progression: A Review. | Med Sci Monit | 2026 | 41560326 | PubTator, text mining | PubMed |
| Cholesterol Deficiency Directs Autophagy-Dependent Secretion of Extracellular Vesicles. | J Extracell Vesicles | 2026 | 41538718 | PubTator, text mining | PubMed |
| LH promotes testosterone synthesis in rooster leydig cells through YAP1/ACSL4/SOAT1 pathway. | Theriogenology | 2026 | 41529502 | PubTator, text mining | PubMed |
| A multifunctional nanozyme integrating panoptosis induction and T-cell metabolic reprogramming to augment the efficacy of PD-1 inhibitors. | Colloids Surf B Biointerfaces | 2026 | 41481959 | PubTator, text mining | PubMed |
| Albumin Nanoparticles Co-Loaded with Dual Drugs for Enhanced Ferroptosis-Based Cancer Therapy through Modulating Cholesterol Metabolism. | ACS Nano | 2026 | 41481031 | PubTator, text mining | PubMed |
| Adrenocortical Mitochondria-Associated Membranes: Isolation, Characterization, and Lipidoproteomic Response to Mitotane. | J Endocr Soc | 2026 | 41472891 | PubTator, text mining | PubMed |
| Enhanced Co-degradation of chloramphenicol and polyvinyl chloride in water by bioelectrochemical systems. | Water Res | 2026 | 41412025 | PubTator, text mining | PubMed |
| Targeting sterol O-acyltransferase 1 rewires fatty acid metabolism and uncovers immune vulnerability in hepatocellular carcinoma. | Hepatology | 2026 | 41066331 | PubTator, text mining | PubMed |
| [p53-SOAT1 Axis: A Novel Target for Tumor Lipid Metabolism and Therapy]. | Zhongguo Fei Ai Za Zhi | 2025 | 41777063 | PubTator, text mining | PubMed |
| Stimulated Raman Scattering Imaging Enabled Biomarker Discovery for Precision Medicine. | Chem Biomed Imaging | 2025 | 41450476 | PubTator, text mining | PubMed |
| Constructing genotype and phenotype network helps reveal disease heritability and phenome-wide association studies. | BMC Genomics | 2025 | 41382283 | PubTator, text mining | PubMed |
| Lipid Composition and Thermotropic Properties of Meibum of Animal Models and Humans with Meibomian Gland Dysfunction. | Int J Mol Sci | 2025 | 41373590 | PubTator, text mining | PubMed |
| Exploring Monodora myristica seed oil compounds as inhibitors of sterol O-Acyltransferase 1: implications for lipid-associated diabetic complications. | In Silico Pharmacol | 2025 | 41357416 | PubTator, text mining | PubMed |
| Rho-ROCK signaling and α-Catenin mediate β-Catenin-driven hyperplasia in the adrenal via adherens junctions. | bioRxiv | 2025 | 41279167 | PubTator, text mining | PubMed |
| Novel Role of AcylCoA:cholesterol acyltransferase 1 (ACAT1/SOAT1) in Diabetic Retinopathy. | bioRxiv | 2025 | 41279083 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6646/papers?page=3